These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15703362

  • 1. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
    Narang VS, Lulla A, Malhotra G, Purandare S.
    J Clin Pharmacol; 2005 Mar; 45(3):265-74. PubMed ID: 15703362
    [Abstract] [Full Text] [Related]

  • 2. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Rao Thudi N, Koundinya Tippabhotla S, Khuroo A, Marwah A, Kumar Shrivastav V, Tandon M, Raghuvanshi R, Biswal S.
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [Abstract] [Full Text] [Related]

  • 3. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Reyar S, Tiwari HK, Tippabhotla SK, Khuroo A, Thudi NR, Ahmed S, Raghuvanshi R.
    Arzneimittelforschung; 2009 Dec; 59(2):104-8. PubMed ID: 19338141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
    Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.
    AIDS; 2007 Jan 02; 21(1):59-64. PubMed ID: 17148968
    [Abstract] [Full Text] [Related]

  • 6. Bioequivalence evaluation of a fixed dose combination lamivudine + stavudine tablet with concurrent administration of lamivudine tablet and stavudine capsule in healthy volunteers.
    Chachad S, Lulla A, Malhotra G, Purandare S.
    Arzneimittelforschung; 2009 Jan 02; 59(10):537-40. PubMed ID: 19998583
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
    Marier JF, Dimarco M, Guilbaud R, Dodard C, Morelli G, Tippabhotla SK, Singla AK, Thudi NR, Monif T.
    J Clin Pharmacol; 2007 Nov 02; 47(11):1381-9. PubMed ID: 17962426
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations.
    Mukherjee A, Singla M, Velpandian T, Sirohiwal A, Vajpayee M, Singh R, Kabra SK, Lodha R.
    Indian Pediatr; 2014 Mar 02; 51(3):191-7. PubMed ID: 24736906
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
    Vezina HE, Henry K, Ravindran GD, Kurpad AV, Raj TD, Fox K, Weller D, Brundage RC, Cavert W, Balfour HH.
    J Acquir Immune Defic Syndr; 2006 Feb 01; 41(2):131-6. PubMed ID: 16394842
    [Abstract] [Full Text] [Related]

  • 14. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
    Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S.
    J Med Assoc Thai; 2007 Feb 01; 90(2):244-50. PubMed ID: 17375627
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies.
    Kano EK, dos Reis Serra CH, Koono EE, Andrade SS, Porta V.
    Int J Pharm; 2005 Jun 13; 297(1-2):73-9. PubMed ID: 15907596
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
    Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E.
    AIDS; 2007 Mar 30; 21(6):768-71. PubMed ID: 17413701
    [Abstract] [Full Text] [Related]

  • 19. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
    Ellis JC, L'homme RF, Ewings FM, Mulenga V, Bell F, Chileshe R, Molyneux E, Abernethy J, van Oosterhout JJ, Chintu C, Walker AS, Gibb DM, Burger DM.
    Antivir Ther; 2007 Mar 30; 12(2):253-60. PubMed ID: 17503667
    [Abstract] [Full Text] [Related]

  • 20. Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study.
    Nirogi R, Kandikere V, Komarneni P, Aleti R, Padala N, Kalaikadhiban I, Bhyrapuneni G, Muddana N.
    Biomed Chromatogr; 2012 Dec 30; 26(12):1472-81. PubMed ID: 22344535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.